US health agency questions the robustness of AstraZeneca’s COVID-19 vaccine trial data
(Reuters) – AstraZeneca Plc may have given an incomplete overview of the efficacy data on its large-scale COVID-19 vaccine in the U.S. trial, a U.S. health agency said Tuesday in a new setbac…
